Calumet Specialty Products Partners, L.P. (CLMT) Stock Forecast
CLMT analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.67 / 5 from 6 analysts
- Price target
- $53.40 average of analyst targets
- Upside to target
- −7.5% from the latest close
- Next earnings
- November 6, 2026 EPS estimate $1.10
- 52-week range
- $18.22 – $59.05
CLMT analyst ratings
6 analystsNumber of analysts at each rating.
CLMT price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CLMT earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.57 | $1.57 | $1.57 | $0.20 | +666.6% | 1 |
| Current fiscal year (2026) | −$2.68 | −$2.68 | −$2.68 | −$0.47 | −466.5% | 1 |
| Next fiscal year (2027) | $0.63 | $0.63 | $0.63 | −$2.68 | +123.5% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CLMT revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.26B | $1.15B | $1.37B | +17.0% | 6 |
| Current fiscal year (2026) | $4.93B | $4.69B | $5.21B | +19.2% | 6 |
| Next fiscal year (2027) | $4.70B | $3.94B | $5.50B | −4.8% | 6 |
CLMT EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CLMT revenue: reported and forecast
CLMT EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.34 | $0.47 | $1.00 | $1.00 | $1.57 | +361.8% | 1 up · 0 down |
| Current fiscal year (2026) | −$3.29 | −$2.84 | $0.00 | $0.00 | −$2.68 | −18.5% | 1 up · 0 down |
| Next fiscal year (2027) | $0.31 | $0.42 | $0.63 | $0.63 | $0.63 | +103.2% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CLMT earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CLMT beat in 6 of 12.
What analysts expect from CLMT
6 analysts cover Calumet; their consensus rating is buy (3.67 on a 1–5 scale, where 5 is a strong buy). The average price target is $53.40, 7.5% below the latest close of $57.75. Analysts expect earnings of −$2.68 per share for 2026, −466.5% from a year earlier. For 2027 the average estimate is $0.63 per share on revenue of $4.7 billion. Calumet beat the EPS estimate in 6 of the last 12 quarters.
Related: CLMT income statement, CLMT key metrics, CLMT chart. See the CLMT stock overview for the latest quote and news.
CLMT forecast FAQ
What is Calumet's price target?
The average analyst price target for Calumet is $53.40, 7.5% below the latest close of $57.75.
Is Calumet a buy, hold or sell?
Of 6 analysts covering Calumet, 2 rate it a strong buy, 0 a buy, 4 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Calumet's EPS forecast?
Analysts forecast −$2.68 per share for 2026 (range −$2.68 to −$2.68); for 2027 the estimate is $0.63.
What is Calumet's revenue forecast?
The average revenue estimate for 2026 is $4.9 billion, growth of 19.2%; for 2027 it is $4.7 billion.
When does Calumet report earnings?
Calumet is expected to report results for the quarter ending September 30, 2026 on November 6, 2026 before the market opens; the EPS estimate is $1.10.
Does Calumet usually beat earnings estimates?
Calumet reported EPS at or above the analyst estimate in 6 of the last 12 quarters.